Primary Objective:~Determine response rate (RR; complete and partial response [CR, PR]) and duration after therapy with Aroplatin™ in patients with advanced solid malignancies.~Secondary Objective:~Determine the safety and tolerability of Aroplatin
To determine the rate of response and the duration of the response following therapy with Aroplatinin patients with advanced solid malignancies.